INVO Fertility Files 8-K on Equity Sales and Shareholder Votes

Ticker: IVF · Form: 8-K · Filed: Jul 23, 2025 · CIK: 1417926

Sentiment: neutral

Topics: equity-sale, shareholder-vote, corporate-action

TL;DR

INVO Fertility sold equity and had shareholder votes on July 17th.

AI Summary

On July 17, 2025, INVO Fertility, Inc. reported on the unregistered sale of equity securities and the submission of matters to a vote of security holders. The company, formerly known as NAYA Biosciences, Inc., is incorporated in Nevada and headquartered in Sarasota, Florida.

Why It Matters

This filing indicates potential new equity issuance and shareholder decisions, which could impact the company's capital structure and future direction.

Risk Assessment

Risk Level: medium — Filings related to equity sales and shareholder votes can signal changes in company ownership, dilution, or strategic shifts that may carry inherent risks.

Key Players & Entities

FAQ

What specific equity securities were sold unregistered?

The filing does not specify the exact type or amount of unregistered equity securities sold, only that such a sale occurred.

What matters were submitted to a vote of security holders?

The filing indicates that matters were submitted to a vote, but the specific details of these matters are not provided in the provided text.

When was INVO Fertility, Inc. formerly known as NAYA Biosciences, Inc.?

The company's name change from NAYA Biosciences, Inc. to INVO Fertility, Inc. occurred on October 22, 2024.

What is the company's primary business classification?

The company's Standard Industrial Classification is SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841].

Where is INVO Fertility, Inc. headquartered?

INVO Fertility, Inc. is headquartered at 5582 Broadcast Court, Sarasota, FL 34240.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 23, 2025 regarding INVO Fertility, Inc. (IVF).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing